Chimeric antigen receptor T-cell therapy uses a patients' T-cells to fight cancer. Although more than half of recipients go into remission, the treatment costs $375,000 to $475,000, NBC News reported.
Uncategorized
September 2022 Issue of Becker’s Hospital Review ON THE COVER 91 statistics on physician compensation | 2022 With healthcare workforce shortages persisting as a significant problem for hospitals and health systems, it is important to look at how physician compensation…
Six oncologists have joined new practices or received new appointments since Aug. 1.
Naples, Fla.-based radiation oncologist Chaundre Cross, MD, has been presumed lost at sea after a 100-hour search, NBC News reported Aug. 16.
Sioux Falls, S.D.-based Sanford Health has delayed construction of its new heart center, Inforum reported Aug. 22.
Cerritos, Calif.-based Oncology Institute and Blue Note Therapeutics have partnered to provide digital mental health treatment for cancer patients.
In a new report updating knowledge of cardiovascular disease symptoms, the American Heart Association highlights the importance race and gender play and calls for further study of these differences.
Los Angeles-based researchers found that stage IV cervical cancer diagnoses are on the rise. Here are five findings from their study published Aug. 18 in the International Journal of Gynecological Cancer.
The National Cancer Institute, part of the National Institutes of Health, awarded $23 million to four academic institutions to study the role of telehealth in cancer healthcare.
N.J.-based Hackensack University Medical Center became the second hospital in the world to implant the Impella Bridge-to-Recovery heart pump, New Jersey Business Magazine reported Aug. 18.